Kodiak Sciences (KOD) Payables (2017 - 2026)
Kodiak Sciences (KOD) reported Payables of $11.3 million for Q1 2026, up 73.38% on a YoY basis from $6.5 million in Q1 2025, and down 11.81% quarter-over-quarter from $12.9 million in Q4 2025.
Kodiak Sciences (KOD) Payables (2017 - 2026) Analysis & Trends
Kodiak Sciences has reported Payables for 10 years, with the latest figure at $11.3 million in Q1 2026.
- For the quarter ending Q1 2026, Payables rose 73.38% year-over-year to $11.3 million; the trailing twelve-month figure through Mar 2026 stood at $11.3 million (up 73.38% YoY), and the FY2025 full-year result was $12.9 million, up 228.56% from the prior year.
- Payables for Q1 2026 stood at $11.3 million, down from $12.9 million in the prior quarter.
- The five-year high for Payables was $38.6 million in Q3 2023, with the low at $1.9 million in Q2 2024.
- Historically, Payables has averaged $11.0 million across 5 years, with a median of $10.4 million in 2025.
- Annual changes were most pronounced in 2022 — Payables soared 653.51% — and 2024, when it tumbled 91.47%.
- Kodiak Sciences' Payables stood at $9.1 million in 2022, then jumped by 49.05% to $13.6 million in 2023, then plunged by 71.23% to $3.9 million in 2024, then jumped by 228.56% to $12.9 million in 2025, then retreated by 11.81% to $11.3 million in 2026.
- The last three Payables figures came in at $11.3 million (Q1 2026), $12.9 million (Q4 2025), and $10.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 8.69 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 34.55 Mn |
| 10 | Kodiak Sciences | 1.95 Bn | 1.95 Bn | - | 11.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.34 Mn |
| Dec 31, 2025 | 12.86 Mn |
| Sep 30, 2025 | 10.37 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Mar 31, 2025 | 6.54 Mn |
| Dec 31, 2024 | 3.92 Mn |
| Sep 30, 2024 | 3.29 Mn |
| Jun 30, 2024 | 1.87 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | 13.61 Mn |
| Sep 30, 2023 | 38.59 Mn |
| Jun 30, 2023 | 12.35 Mn |
| Mar 31, 2023 | 6.26 Mn |
| Dec 31, 2022 | 9.13 Mn |
| Sep 30, 2022 | 15.61 Mn |
| Jun 30, 2022 | 20.63 Mn |
| Mar 31, 2022 | 13.07 Mn |
| Dec 31, 2021 | 12.43 Mn |
| Sep 30, 2021 | 13.76 Mn |
| Jun 30, 2021 | 2.74 Mn |